Bb-2121
Drug
General payments
$231,662
Research payments
$11,225,161
Through program year 2019, $231,662 in general payments and $11,225,161 in research payments were reported against Bb-2121.
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | General | $231,662 | 273 |
| 2019 | Research | $11,225,161 | 61 |
Breakdown
The top 5 of 40 recipients; each share is of general payments naming this product in 2019.
The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.
The top 5 of 21 states; each share is of general payments naming this product in 2019 where a state was reported.
Records
273 general · 61 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.